Prognosis evaluation and follow-up of resistant trophoblastic neoplasia.

ZHAO Jun; XIANG Yang.

doi:10.7504/fk2015020111

PDF(654 KB)

Chinese Journal of Practical Gynecology and Obstetrics ›› 2015, Vol. 31 ›› Issue (3) : 223-226. DOI: 10.7504/fk2015020111

Prognosis evaluation and follow-up of resistant trophoblastic neoplasia.

ZHAO Jun,XIANG Yang.

Author information +

History +

Abstract

Abstract:Although most patients with gestational trophoblastic neoplasms have optimistic prognosis due to their sensitivity to the chemotherapy, approximately ten to twenty-five percent of them might develop resistance to the primary chemotherapy.The present article gives a brief introduction to evaluating the prognosis and follow-up of the resistant gestational trophoblastic neoplasms.

Key words

gestational trophoblastic neoplasms / resistant / prognosis / follow-up

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHAO Jun,XIANG Yang.. Prognosis evaluation and follow-up of resistant trophoblastic neoplasia.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2015, 31(3): 223-226 https://doi.org/10.7504/fk2015020111

References

［1］    向阳.宋鸿钊滋养细胞肿瘤学［M］.3版.北京:人民卫生出版社,2011：301.

［2］   Lurain JR.Gestational trophoblastic disease Ⅱ: classification and management of gestational trophoblastic neoplasia［J］.Am J Obstet Gynecol,2011，204(1):11-18.

［3］   Wang J, Short D, Sebire NJ,et al.Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE) ［J］.Ann Oncol，2008，19(9):1578-1583.

［4］   Feng F, Xiang Y, Li L, et al.Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia［J］.Gynecol Oncol，2009，113(3):312-315.

［5］   Zhao J, Xiang Y，Wan XR, et al.Molecular genetic analyses of Choriocarcinoma［J］.Placenta，2009,30(9):816-820.

［6］   Alifrangis C, Agarwal R, Short D,et al.EMA-CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis［J］.J Clin Oncol，2013，31(2):280-286.

［7］   Kingdon SJ, Coleman RE, Ellis L,et al.Deaths from gestational trophoblastic neoplasia: any lessons to be learned? ［J］.J Reprod Med，2012 ，57(7-8):293-296.

［8］   Patel SM, Desai A.Management of drug resistant gestational trophoblastic neoplasia［J］.J Reprod Med，2010，55(7-8):296-300.

［9］    周莹，冯凤芝，向阳，等.耐药和复发性妊娠滋养细胞肿瘤的临床病例分析［J］.中华妇产科杂志，2010，45（11）：804-807.

［10］    Alazzam M, Tidy J, Osborne R,et al.Chemtherapy for resistant or recurrent gestational trophoblastic neoplasia［J］.Cochrane Database Syst Rev，2012，12:CD008891.doi: 10.1002/14651858.CD008891.pub2.